location: Current position: Home >> Scientific Research >> Paper Publications

Preparation and drug-release behavior of 5-fluorouracil-loaded poly(lactic acid-4-hydroxyproline-polyethylene glycol) amphipathic copolymer nanoparticles

Hits:

Indexed by:期刊论文

Date of Publication:2007-02-15

Journal:JOURNAL OF APPLIED POLYMER SCIENCE

Included Journals:SCIE、EI

Volume:103

Issue:4

Page Number:2654-2659

ISSN No.:0021-8995

Key Words:microencapsulation; polyesters

Abstract:Poly(lactic acid-4-hydroxyproline-polyethylene glycol) (PLA-Hpr-PEG) was synthesized via melt copoly-merization with stannous chloride as a catalyst activated by a proton acid. Copolymers with different poly(ethylene glycol) (PEG) concentrations (0.1, 0.5, 1, and 5 wt %) were synthesized and exhibited moderate molecular weights (weight-average molecular weight = 9705-13,600 g/mol) and reasonable molecular weight distributions (weight-average molecular weight/number-average molecular weight = 1.35-1.66). The structure of the polymers was verified with infrared spectroscopy and proton nuclear magnetic resonance spectroscopy. The nanoparticles were made by the nanoprecipitation method with PLA-Hpr-PEG. The size and size distribution of the nanoparticles were investigated with laser light scattering, and the surface morphology of the nanoparticles was investigated with transmission electron microscopy. The drug encapsulation efficiency and drug loading content were measured with ultraviolet absorption spectroscopy. The effects of various formulation parameters were evaluated. The prepared nanoparticles were spherical and greater than 100 nm in size. The drug loading content and encapsulation efficiency were greatly influenced by the amount of the copolymer and the volume of the solvent. The PEG content in the polymer could affect the release of drugs from the PLA-Hpr-PEG nanoparticles. (c) 2006 Wiley Periodicals, Sci.

Pre One:聚氨酯预聚物改性聚酚氧的力学性能

Next One:Synthesis and characterization of a novel biodegradable polymer poly(lactic acid-glycolic acid-4-hydroxyproline)